Effect of ranitidine on intragastric pH in clinically normal neonatal foals

Journal of the American Veterinary Medical Association

Volumn 212, Issue 9, 1998, Pages 1407-1412

  Sanchez, L Chris ^a   Lester, Guy D ^a   Merritt, A M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANITIDINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ELECTRODE; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PH MEASUREMENT; PROSPECTIVE STUDY; STOMACH PH;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ANIMALS, SUCKLING; ANTI-ULCER AGENTS; FEMALE; GASTRIC ACIDITY DETERMINATION; HISTAMINE H2 ANTAGONISTS; HORSES; INJECTIONS, INTRAVENOUS; MALE; RANITIDINE; STOMACH;

ANIMALIA; ZEA MAYS;

EID: 0032078064     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Becht JL, Byars TD. Gastroduodenal ulceration in foals. Equine Vet J 1986;18:307-312.
2. Murray MJ. The pathogenesis and prevalence of gastric ulceration in foals and horses. Vet Med 1991;86:815-819.
3. Nappert G, Vrins A, Larybyere M. Gastroduodenal ulceration in foals. Compend Contin Educ Pract Vet 1989;11:338-345.
4. Murray MJ. Aetiopathogenesis and treatment of peptic ulcer in the horse: a comparative review. Equine Vet J 1992;(Suppl 13):63-74.
5. Campbell-Thompson ML, Merritt AM. Gastroduodenal ulceration in foals, in Proceedings. Annu Meet Am Assoc Equine Pract 1987;33:29-40.
6. Mertz HR, Walsh TH. Peptic ulcer pathophysiology. Med Clin North Am 1991;75:799-814.
7. Murray MJ, Grodinsky C. Regional gastric pH measurements in horses and foals. Equine Vet J 1989;(Suppl 7):73-76.
8. Nord KS. Peptic ulcer disease in the pediatric population. Pediatr Clin North Am 1988;35:117-139.
9. Murray MJ. Equine model of inducing ulceration in alimentary squamous mucosa. Dig Dis Sci 1994;39:2530-2535.
10. Murray MJ, Murray CM, Sweeney HJ, et al. Prevalence of gastric lesions in foals without signs of gastric disease: an endoscopic survey. Equine Vet J 1990;22:6-8.
11. Murray MJ. Endoscopic appearance of gastric lesions in foals: 94 cases (1987-1088). J Am Vet Med Assoc 1989;195:1135-1140.
12. Cudd TA. Gastrointestinal system dysfunction. In: Koterba AM, Drummond WA, Kosch PC, eds. Equine clinical neonatology. Philadelphia: Lea & Febiger, 1990;367-442.
13. Campbell-Thompson ML, Brown MP, Slone DE, et al. Gastroenterostomy for treatment of gastroduodenal ulcer disease in 14 foals. J Am Vet Med Assoc 1986;188:840-844.
14. Orsini JA, Donawick WJ. Surgical treatment of gastroduodenal obstructions in foals. Vet Surg 1986;15:205-213.
15. Feldman M, Burton ME. Histamine 2-receptor antagonists: standard therapy for acid-peptic disease. N Engl J Med 1990; 323:1672-1680.
16. Campbell-Thompson ML, Merritt AM. Effect of ranitidine on gastric acid secretion in young male horses. Am J Vet Res 1987; 48:1511-1515.
17. Murray MJ, Grodinsky C. The effects of famotidine, ranitidine, and magnesium hydroxide/aluminum hydroxide on gastric fluid pH in adult horses. Equine Vet J 1992;(Suppl 11):52-55.
18. Murray MJ, Schusser GF. Measurement of 24-h gastric pH using an indwelling pH electrode in horses unfed, fed and treated with ranitidine. Equine Vet J 1993;25:417-421.
19. Baker SJ, Gerring EL. Technique for prolonged, minimally invasive monitoring of intragastric pH in ponies. Am J Vet Res 1993;54:1725-1734.
20. Baker SJ, Gerring EL. Gastric pH monitoring in healthy, suckling pony foals. Am J Vet Res 1993;54:959-964.
21. Andrews FM, Jenkins CC, Frazier D, et al. Gastric secretion in foals: measurement by nasogastric intubation with constant infusion and aspiration. Equine Vet J 1992;(Suppl 13):75-79.
22. Campbell-Thompson ML, Merritt AM. Basal and pentagastrin-stimulated gastric secretion in young horses. Am J Physiol 1990;259:R1259-R1266.
23. Mela GS, Savarino V, Vigneri S. Optimizing the information obtained from continuous 24-hour gastric pH monitoring. Am J Gastroenterol 1992;87:961-966.
24. Mattoli S, Pilotti V, Felice V, et al. Ambulatory 24-hr pH monitoring of esophagus, fundus, and antrum. Dig Dis Sci 1990;35: 929-938.
25. Savarino V, Mela GS, Scalabrini P, et al. 24-h comparison between pH values of continuous intraluminal recording and simultanenus gastric aspiration. Scand J Gastroenterol 1987;22:135-140.
26. Savarino V, Mela GS, Zentilin P, et al. Gastric aspiration versus antimony and glass pH electrodes. Scand J Gastroenterol 1989; 24:434-439.
27. Furr MO, Murray MJ, Ferguson DC. The effects of stress on gastric ulceration, T3, T4, reverse T3 and cortisol in neonatal foals. Equine Vet J 1992;24:37-40.
28. Mela GS, Savarino V, Sumberaz A, et al. Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH, mean or median? Am J Gastroenterol 1990;85:1105-1108.
29. Bourget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? Gastroenterology 1990;99:345-351.
30. Moore EW. The terminology and measurement of gastric acidity. Ann N Y Acad Sci 1967;140:866-874.
31. Erode C, Garner A, Blum AL. Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut 1987;28:1177-1188.
32. Furr MO, Murray MJ. Treatment of gastric ulcers in horses with histamine type 2 receptor antagonists. Equine Vet J 1989; (Suppl 7):77-79.
33. Geor RJ, Petrie L, Papich MG, et al. The protective effects of sucralfate and ranitidine in foals experimentally intoxicated with phenylbutazone. Can J Vet Res 1989;53:231-238.
34. Smith JM, DeBowes RM, Anderson NV, et al. Efficacy of oral ranitidine in the reduction of gastric acid output and the prevention of phenylbutazone-induced gastric ulceration in nursing foals, in Proceedings. Annu Meet Am Assoc Equine Pract 1987;33:113-127.
35. Fontana M, Tornaghi R, Petrillo M, et al. Ranitidine treatment in newborn infants: effects on gastric acidity and serum prolactin levels. J Pediatr Gastroenterol Nutr 1993;16:406-411.
36. Suttle AB, Brouwer KLR. Bile flow but not enterohepatic recirculation influences the pharmacokinetics of vanitidine in the rat. Drug Metab Dispos 1994;22:224-232.
37. Halpern NA, Colucci RD, Turk J, et al. Segmental intestinal absorption of ranitidine: investigative and therapeutic implications. Am J Gastroenterol 1990;85:539-543.
38. Suttle AB, Pollack GM, Brouwer KL. Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profile. Pharm Res 1992;9:350-356.
39. Gedeit RG, Weigle CGM, Havens PL, et al. Control and variability of gastric pH in critically ill children. Crit Care Med 1993; 21:1850-1855.